Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets, CFDs, OTC options or any of our other products work and whether you can afford to take the high risk of losing your money.

69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

5 Top Stories

Oracle Warns on TikTok Ban

Every day, we handpick the 5 Top Stories stock market investors need to know. In 5 minutes, you’ll learn the stocks, CEOs, and money managers moving markets.

Oracle Warns on TikTok Ban

In its annual report released Monday, software firm Oracle [ORCL] said that a TikTok ban could impact its revenues and profits; Oracle provides cloud infrastructure for the social media app. Meanwhile, Reuters reported that the US Commerce Department is investigating the activities of China Mobile [0941:HK], China Telecom [0728:HK] and China Unicom [0762:HK], China’s largest state-controlled telecom carriers, over fears they are passing US cloud data to Beijing.

Airbus Scales Back Estimates

The Airbus [AIR:PA] share price dropped by 12% Tuesday on news that it is cutting its targets for 2024. The firm now expects that its adjusted earnings before interest and taxes will be some €5.5bn, down from €6.5–7bn estimated on 25 April. It also said it would deliver only 770 aircraft this year, down from a previous estimate of 800. Elsewhere, Boeing [BA] has offered to acquire Spirit AeroSystems [SPR] for some $35 per share, Bloomberg reported.

EV Stocks: Latest News

Having met with a rather muted response in Japan, China’s BYD [1211:HK] has launched its third electric vehicle (EV) in the country, the Seal sedan, which went on sale Tuesday for ¥5.3m. Elsewhere, Ferrari [RACE] CEO Benedetto Vigna told CNBC that the firm’s forthcoming all-electric model has “the driving traits” of its gas-powered models. Lastly, as part of cost-cutting efforts, Rivian [RIVN] has reduced the material costs of production by 35%, Reuters reported.

SolarEdge Under Pressure

Announcing that it will offer $300m in convertible senior notes due in 2029, the smart technology firm [SEDG] also said that it may not receive the $11.4m it is owed by its client PM&M Electric, which has filed for Chapter 7 bankruptcy. SolarEdge now expects negative free cash flow of approximately $150m for Q2, as a result of factors including extensions of credit to customers and higher-than-expected working capital requirements.

Wegovy Green Light in China

Novo Nordisk's [NVO] blockbuster weightloss drug Wegovy has been approved in China, it announced Tuesday. The country has the highest number of overweight people in the world. BenevolentAI [BAI:AS] said that its collaboration with AstraZeneca [AZN] has led to a novel autoimmune target being added to its discovery portfolio. Lastly, AstraZeneca’s cancer drug Imfinzi has failed tests of its potential as a follow-up therapy for patients with a type of early-stage lung cancer.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles